文献速递肝胆胰外科

胰体尾腺癌脾血管侵犯程度对复发与生存的影响

Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
PubMed 文献 · Br J Surg · 2021-01-01

本研究纳入2005至2018年接受 upfront 远端胰腺切除术的249例胰体尾腺癌患者,按脾血管侵犯圆周度分为无侵犯、0-180°、180°以上三组。三组5年总生存率分别为38.4%、16.8%、9.7%(P<0.001);脾动脉和静脉均侵犯者5年总生存率低于单支血管侵犯者(7.5% vs 20.2%,P=0.021)。Cox分析显示辅助治疗、R0切除和脾动脉侵犯为独立预后因素。

要点

  • 脾血管侵犯圆周度越大,5年总生存率越低(无侵犯38.4%、0-180°组16.8%、≥180°组9.7%,P<0.001)。
  • 脾动脉和静脉均侵犯者5年总生存率低于仅单支血管侵犯者(7.5% vs 20.2%,P=0.021)。
  • 辅助治疗、R0切除和脾动脉侵犯是胰体尾癌的独立预后因素。

核心结论

  • 脾血管侵犯与胰体尾癌更高的复发率和更低的总生存率相关,作者据此认为可能需要采用新辅助治疗策略。

研究设计与样本

  • 本研究为单中心回顾性研究,纳入2005至2018年接受 upfront 远端胰腺切除术的249例胰体尾腺癌患者。

主要发现

  • 脾血管侵犯患者肿瘤尺寸大于无侵犯患者(3.9 cm vs 2.9 cm,P=0.001),但转移淋巴结数目与无血管侵犯患者相当(1.7 vs 1.4,P=0.241)。
  • 三组5年总生存率差异显著:无侵犯组38.4%、0-180°组16.8%、≥180°组9.7%(P<0.001)。
  • 脾动脉和静脉均侵犯者5年总生存率低于仅单支血管侵犯者(7.5% vs 20.2%,P=0.021)。
  • Cox比例风险分析显示辅助治疗、R0切除和脾动脉侵犯为不良结局的独立预后因素。

关键数值与推荐

  • 脾血管侵犯按圆周度分为三组:1组无侵犯,2组0-180°,3组180°或以上。
  • 5年总生存率:1组38.4%,2组16.8%,3组9.7%(P<0.001)。
  • 脾动脉和静脉均侵犯者5年总生存率7.5%,仅单支血管侵犯者20.2%(P=0.021)。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Major vessel invasion is an important factor for determining the surgical approach and long-term prognosis for patients with pancreatic head cancer. However, clinical implications of vessel invasion have seldom been reported in pancreatic body or tail cancer. This study aimed to evaluate the clinical relevance of splenic vessel invasion with pancreatic body or tail cancer compared with no invasion and investigate prognostic factors. METHODS: This study enrolled patients who underwent upfront distal pancreatectomy from 2005 to 2018. The circular degree of splenic vessel invasion was investigated and categorized into three groups (group 1, no invasion; group 2, 0-180°; group 3, 180° or more). Clinicopathological variables and perioperative and survival outcomes were evaluated, and multivariable Cox proportional analysis was performed to evaluate prognostic factors. RESULTS: Among 249 enrolled patients, tumour size was larger in patients with splenic vessel invasion (3.9 versus 2.9 cm, P = 0.001), but the number of metastatic lymph nodes was comparable to that in patients with no vessel invasion (1.7 versus 1.4, P = 0.241). The 5-year overall survival rates differed significantly between the three groups (group 1, 38.4 per cent; group 2, 16.8 per cent; group 3, 9.7 per cent, P < 0.001). Patients with both splenic artery and vein invasion had lower 5-year overall survival rates than those with one vessel (7.5 versus 20.2 per cent, P = 0.021). Cox proportional analysis revealed adjuvant treatment, R0 resection and splenic artery invasion as independent prognostic factors for adverse outcomes in pancreatic body or tail cancer. CONCLUSION: Splenic vessel invasion was associated with higher recurrence and lower overall survival in pancreatic body or tail cancers suggesting a need for a neoadjuvant approach.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Kang JS, Choi YJ, Byun Y, et al. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival. Br J Surg. 2021. PMID: 34718433. doi:10.1093/bjs/znab357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。